Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great point 'stang. That helps put the situation in perspective. Also, if you look at the press releases since McNally came aboard they are consistently at least one or two per month. It's hard to see his work in the frantic microscope through which we parse our woes daily, but pulling back and taking stock of the last 6 months we can see McNally is doing more in less time. He was just handed a dooky sandwich making it harder to proceed than when money was fast and loose. I often ponder - let's say things work out well and the PPS grows to a healthy range organically - would I, or anyone here, still pull out? It would be hard to remeber these times with the dollar sign goggles on...my plan would be to wait until I could withdraw my original investment and have some leftover to keep. A form of Stockholm syndrome? Then there's always the concern over selling too soon regret, like those who sold ISRG at $20 or $100. ? Hindsight is 20/20 ...no crystal balls, just balls. Takes them to hang in with Titan, at least we can take solace in that.
I sacrificed my student email account to download that report...rubbish. it's just a technical analysis which is irrelevant for the most part until we start seeing cashflows. You can find that same information anywhere. Do not download and you're welcome.
We shouldn't forget a tremendous asset we have which will propel us when we get to market - customer's resentment and disdain for intuitive.
It would make sense to enter the Asian markets as a Hail Mary pass...lower regulatory barriers - they could commence sales much sooner theoretically, getting cash flows to the firm and enticing investors. Hmmm.... tricky Mc at work?
I think this is a positive move.
So what? I've been an investor since 2015 just have not posted here. I'm still hanging in there too. Issuing debt doesn't make sense right now. As a last ditch, sure. Otherwise how do you propose we service that debt?
You nailed it DRG1025. 66 stang - what happens along the way does matter if it involves driving head first into a 100 year old great oak at 90mph.
Hypocrates is right we need drastic measures but I don't agree debt is the solution right now. In fact with no cash flows slated until 2019 (at best) and equity raises floundering it's a sure way to bankrupt the company.
DRG here's what I think big investors see that keep them away:
10 years in existence
Less cash than required
0 products in the market
'Nuff said
Gang - I don't know what, but something is happening todayou. We've been flat at $.11 all morning...why?
I don't know the details but theoretically Nicholson would get some kind of remuneration be it royalties or fee for service. Another major reason is goodwill, It behooves Nicholson for their reputational capital...this helps them stay on the cutting edge of surgical robotics.
It seems Titan is between a rock and a hard place. With Goliaths a entering the arena from all directions, can sport compete or did it miss it's window? Millions of dollars and a decade wasted. How can we make the rest of the funding to complete the next two years? Two years too late? It seems all are waking up to what I've been trying to say lately: we're not raising capital we need and we're too diluted to begin with. We have to make an honest assessment of what things are and not what we want things to be. It's true whats being said, things are not looking great. I think the best thing we can hope for at this point is a buy out by a hungry firm like merit medical, stryker, or conmed. Then maybe someday our grandchildren will see a break-even on our initial investment.
66 where did you come up with 333k shares outstanding? That's a big difference to the 237M now! I believe part of what's holding us back is the massive number of outstanding shares.
DRG I can't say I'm experienced with IP valuations so I'm just shooting from the hip. The PV I ended up with was $40M at the end of year 1 of sales. The market cap now is a little over half that..so I'd say it's not unreasonable to expect a buyout share price over $1 but only after a RS. That seems to be the issue - outstanding shares; profit is thin at the current quantity.
BigT I pray you're right! My avg PPS is 0.3031 so I'm hurting now as I'm sure are most. I thought 0.25 was rock bottom, so seeing the continued dive fuels my skepticism. I agree McNabbers and crew are killing it lately, he's given solid milestones and appears to be on course. He's done a great job marketing as mentioned in a previous post. This gives me confidence. Leadership was the missing component previously. I think in 5 - 10 years those of us who wait out the storm could be well rewarded. I've given up the idea that my shares will make me into a millionaire in short order. There's no such thing as a free lunch.
Equities prices are based on the present value of (expected) future cash flows.
Preface: this is in the spirit of dialogue, I'm not trolling. I have 42860 shares in titxf so my hopes lie with the prosperity of this firm. It's got great potential. But let's take an honest look at the recurring question "why we so low?"
As we have no cash flows or net margin currently, our value is based on intangibles like our IP assets, which analysts have priced at $0.11/share. With 237M outstanding shares, only after a RS and sales begin to roll in, dividends are issued (estimating a P/E around ISRG's of 47 and using the conservative sales curve from the most recent report, as well as a risk-free-rate of 2.6%) our share price could be around $4-6. This is my quick GGM analysis, I'm interested to see others. Until then we may get pump and dumps etc, but I'm telling you, until sales commence our value is based on possibility which is exciting but doesn't pay the bills. This is why I'm skeptical of a natural PPS hike...why would it happen? We've seen good news doesn't seem to change minds thus far. We need sales!
Prove me wrong! What do you think?!
Regards,
Quid
No companies have purchased the stock because it's still too risky. The competition is waiting until sport poses a real threat. Why pay to eliminate a potential competitor that may still flop on its own, at no cost to you! If it's viable technology and generates consistent cash flows then companies will take a look.
I hate to say it but honeycomb makes some valid points. If they do the RS at $0.11 PPS It will take a lot longer to get back to break even (for me it would be at a PPS of $9.10). That sucks. How long will that take a decade? And that's assuming the price rises. The more likely scenario after the uplist is shorts and price deflation due to dilution and no revenue from sales. So it will turn my 65% loss into a much deeper one. I can't blame anyone it was my choice to invest. The best thing for us waiting this storm out would be to try and rally the PPS up before the RS to limit our losses. But management probably perceives survival resting on the uplist and can't afford to wait the prices up. The uplist is definitely needed to attract the investors required to get to market.
Craton is right. The only thing that will move the meter is when we have units rolling off the production line. At this point, with all the good news we've had to no effect, it wouldn't matter if Jesus came back and endorsed SPORT. Unless and until there's a saleable product we'll continue to limbo.
Forgive my ignorance - who/what are the MMs?
Good points surg tech. Then SPORT could be a lower cost alternative. I think the main value proposition will be the price tag. The lower cost may be the difference between squeezing a robot into the capital budget this year or not, which I'm sure many surgeons would push for. It's still a long road ahead and I hope McNally is practicing up with his slingshot ;)
Noe - your points are correct about what else Mc needs to do. I've been an investor since 2015, I've read the press releases, seen the presentations, scoured the articles, and the value proposition is lower cost, lower profile, clear FOV to surgical site for surgeon, 3D camera, smaller unit. It's indicated for broad smaller/Outpatient surgeries. The SP is only indicated for urological procedures but surgeons can use devices outside of manufacturers indications. Can the features of SPORT can best the SP? if anything they're very similar.
I'm like everyone else, I've got my eyes to the sky. I'd like things to pan out. but I've got a deeper doubt now that SP is seated to undermine the whole concept that made SPORT unique. Let me know where I'm wrong....I pray I am!
Correction: if the *SP is released later this year
McNally needs to answer the question: what makes SPORT a more attractive investment for hospitals and surgeons than the DaVinci SP? Price is important but it's not everything. Why go with an unproven robot which you're not certain will be around/supported for the next 5 years when you could spend a little more for the security of ISRG? If the SPORT is released later this year does it spell certain doom for SPORT? Basically, if ISRGS does it first and better, where does that leave us?
I'dunno venture the supply and demand curves dictat PPS is going to have to go down drastically to attract enough orders to fill the volume. I would hold off. I see the PPS sinking to around $.05 in the coming months. But then again what do I know, I'm sitting here with a 66% loss from what I thought was a stellar average cost basis of $0.3031.
Big day indeed!
On the bright side a good buying opportunity should present itself, by next week at this rate, when PPS reaches $0.0001.
I'm long on titxf so this volatility doesn't bother me but I'm amazed at how adverse this stock has been to good news.